MABISANG proteksyon ang tatlong shot ng Pfizer/BioNTech Covid-19 vaccine laban sa pinakabagong variant na Omicron, ayon sa pag-aaral ng mga Israeli researchers.
Nauna nang sinabi ng Pfizer at BioNTech na mabisa ang kanilang booster shot bilang proteksyon laban sa Omicron.
“People who received the second dose 5 or 6 months ago do not have any neutralization ability against the Omicron. While they do have some against the Delta (strain),” ayon kay Gili Regev-Yochay, director ng Infectious Diseases Unit ng Sheba Medical Center at Health Ministry’s Central Virology Laboratory.
“The good news is that with the booster dose it increases about a hundred fold. There is a significant protection of the booster dose. It is lower than the neutralization ability against the Delta, about four times lower,” dagdag pa niya.
